Skip to content

Intracel Corp.

United StatesFDA applicant, unverified

Devices
5

What Intracel Corp. makes

Intracel Corp. manufactures in vitro diagnostic tests for detecting and identifying infectious agents and monitoring immune cell counts. Their portfolio includes antigenemia assays for cytomegalovirus (CMV), ELISA tests for Legionella in urine, and respiratory pathogen screening kits. They also produce a CD4/CD8 cell monitoring kit for immune cell analysis.

The company’s diagnostic tests are classified under FDA’s Class I and Class II categories, with regulatory submissions recorded in the 510(k) pathway. Their products are listed under the FDA’s regulatory framework and are based in the United States.

AI-generated from registry data, 1 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue5

Newest first, rows 1-5 of 5

Frequently asked questions

How many devices does Intracel Corp. have in the registry?

The registry currently lists 5 devices for Intracel Corp.. Devices recorded under merged duplicate company entries are counted once.

Which registries list Intracel Corp.'s devices?

Among its 5 most recently registered devices, Intracel Corp. has devices listed in FDA 510(k) (5 devices).

What risk classes do Intracel Corp.'s devices fall under?

Among its 5 most recently registered devices, the classes recorded for Intracel Corp.'s devices are Class I and Class II. Each device page shows its own class and authorisation.

What are the newest devices from Intracel Corp. in the registry?

The most recently registered devices listed for Intracel Corp. include BARTELS CINAKIT CMV ANTIGENEMIA, PRIMA SYSTEM - OLD, BARTELS ELISA - NEW, BARTELS LEGIONELLA URINARY ANTIGEN ELISA TEST and BARTELS VIRAL RESPIRATORY SCREENING AND IDENTIFICATION KIT.

Generated automatically from registry data and not verified by a human reviewer.